WEPDC0106 - Poster Discussion Abstract
HIV sero-prevalence in trans population in 7 urban areas in Mexico
Presented by Héctor Sucilla Pérez (Mexico).
H. Sucilla Pérez1, J.P. Gutierrez Reyes2, A.R. Shiba Matsumoto3, J.A. Izazola Licea4
1CENSIDA, Operational Research, Mexico DF, Mexico, 2National Institute of Public Health, CIEE, Cuernavaca, Mexico, 3National Institute of Public Health, Cuernavaca, Mexico, 4CENSIDA (at the Time of the Study and Analysis), Mexico DF, Mexico
Background: Trans population had been considered historically
included in the MSM group (part of them), specially for epidemiological and
behavioral research. There is evidence that trans population have higher risk of
HIV infection and faces more inequity situations than general MSM population.
Considering UNAIDS and other international recommendations about trans
population data disaggregation, CENSIDA promoted this survey.
Methods: In 2012, a cross-sectional survey linked to HIV
serology rapid test among trans population (transgender, transexual and
traviesti), was implemented in meeting places of 7 urban areas from
Jalisco, Veracruz and Estado de México. The collected data included general
socio-demographic characteristics, risk factors and sexual behaviors. Tested
trans population received pre and post counseling, and when the result of the
two rapid tests were reactive, the person was considered as HIV sero-reactive.
Results: In total, 420 trans persons were interviewed,
of these, 410 accepted the application of two HIV rapid tests. HIV
sero-prevalence in trans population of this study was 15.21% (IC95% 7.56% -
28.24%). Self report results indicates that of those non-reactive, 30.4% (27.2-33.7)
were not aware of their status, 68.0% (64.6-71.3) self-reported being no
reactive, and 1.6% (0.8-3.0) assumed that they were living with HIV. Of those
that were sero-reactive 37.7% (17.7-63.0) assumed they were not living with HIV,
23.0% (12.1-39.2) were not aware of their status and 30.9% (19.5-45.3) reported
that they were living with HIV.
Conclusions: Observed sero-prevalence of HIV in trans
population of meeting places in this study resulted higher than the observed in
a sample of 1,110 MSM who accepted two rapid tests in the same cities, 15.21%
in trans (IC95% 7.56% - 28.24%) vs 12.16% (IC95% 6.61% - 17.69%) in MSM
respectively. These results could support the hypothesis that trans population
could be more affected than MSM by the HIV epidemic in Mexico as well as in
other regions. Self report results about HIV infection status, shows that trans
population testing initiatives must be improved and implemented in order to
detect those living with HIV and refer them to health services. Studies in this
population must be prioritized and developed in a continuous and permanent way.
Back to the Programme-at-a-Glance